Cell-of-origin of cancer versus cancer stem cells: Assays and interpretations

Cancer Research

Volumn 75, Issue 19, 2015, Pages 4003-4011

  Rycaj, Kiera ^a   Tang, Dean G ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASSAY; CANCER CELL; CANCER INITIATING CELL; CANCER PROPAGATING CELL; CANCER RECURRENCE; CANCER STEM CELL; CANCER TRANSPLANTATION; CELL HETEROGENEITY; CELL LINEAGE; CELL POPULATION; HUMAN; LINEAGE TRACING ASSAY; MALIGNANT TRANSFORMATION; METASTASIS; NONHUMAN; PRIORITY JOURNAL; TRANSPLANTATION ASSAY; ANIMAL; ANTIBODY SPECIFICITY; BIOLOGICAL MODEL; CELL CLONE; CELL SELF-RENEWAL; CELL SEPARATION; CELL TRANSFORMATION; CELL TRANSPLANTATION; CYTOLOGY; EPITHELIUM CELL; GENETICS; MOUSE; MUTATION; NEOPLASMS; NONOBESE DIABETIC MOUSE; NUDE MOUSE; PATHOLOGY; SCID MOUSE; TRANSPLANTATION; XENOGRAFT;

ANIMALS; CELL LINEAGE; CELL SELF RENEWAL; CELL SEPARATION; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSPLANTATION; CLONE CELLS; EPITHELIAL CELLS; HETEROGRAFTS; HUMANS; MICE; MICE, INBRED NOD; MICE, NUDE; MICE, SCID; MODELS, BIOLOGICAL; MUTATION; NEOPLASM TRANSPLANTATION; NEOPLASMS; NEOPLASTIC STEM CELLS; ORGAN SPECIFICITY; TRANSPLANTATION, HETEROLOGOUS;

EID: 84945566332     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-15-0798     Document Type: Article

References (30)

1. Visvader JE. Cells of origin in cancer. Nature 2011;469:314-22.
2. Tang DG. Understanding cancer stem cell heterogeneity and plasticity. Cell Res 2012;22:457-72.
3. Kreso A, Dick JE. Evolution of the cancer stem cell model. Cell Stem Cell 2014;14:275-91.
4. Passey RD, Dmochowski L, Lasnitzki I, Millard A. Cultivation in vitro of frozen and desiccated mouse tumour tissues. Br Med J 1950;2:1134-6.
5. Hewitt HB. Studies of the quantitative transplantation of mouse sarcoma. Br J Cancer 1953;7:367-83.
6. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:3983-8.
7. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature 2004;432: 396-401.
8. Qin J, Liu X, Laffin B, Chen X, Choy G, Jeter CR, et al. The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration. Cell Stem Cell 2012;10:556-69.
9. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumor growth in immunodeficient mice. Nature 2007;445:106-10.
10. Goldstein AS, Huang J, Guo C, Garraway IP, Witte ON. Identification of a cell of origin for human prostate cancer. Science 2010;329:568-71.
11. Taylor RA, Toivanen R, Frydenberg M, Pedersen J, Harewood L, Australian Prostate Cancer B, et al. Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 status. Stem Cells 2012;30:1087-96.
12. Domingo-Domenech J, Vidal SJ, Rodriguez-Bravo V, Castillo-Martin M, Quinn SA, Rodriguez-Barrueco R, et al. Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch-and hedgehog-dependent tumor-initiating cells. Cancer Cell 2012;22:373-88.
13. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, Morrison SJ. Efficient tumour formation by single human melanoma cells. Nature 2008;456:593-8.
14. Boiko AD, Razorenova OV, van de Rijn M, Swetter SM, Johnson DL, et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 2010;466:133-7.
15. Kelly PN, Dakic A, Adams JM, Nutt SL, Strasser A. Tumor growth need not be driven by rare cancer stem cells. Science 2007;317:337.
16. Vermeulen L, De Sousa E, Melo F, van der Heijden M, Cameron K, de Jong JH, Borovski T, et al. Wnt activity defines colon cancer stem cells and is regulated by the microenvironment. Nat Cell Biol 2010;12:468-76.
17. Liu J, Pascal LE, Isharwal S, Metzger D, Ramos Garcia R, Pilch J, et al. Regenerated luminal epithelial cells are derived from preexisting luminal epithelial cells in adult mouse prostate. Mol Endocrinol 2011;25:1849-57.
18. Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG, et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012;488:522-6.
19. Schepers AG, Snippert HJ, Stange DE, van den Born M, van Es JH, van de Wetering M, et al. Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas. Science 2012;337:730-5.
20. Driessens G, Beck B, Caauwe A, Simons BD, Blanpain C.Defining the mode of tumour growth by clonal analysis. Nature 2012;488:527-30.
21. Wang X, Kruithof-de Julio M, Economides KD, Walker D, Yu H, Halili MV, et al. A luminal epithelial stem cell that is a cell of origin for prostate cancer. Nature 2009;461:495-500.
22. Wang ZA, Mitrofanova A, Bergren SK, Abate-Shen C, Cardiff RD, Califano A, et al. Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity. Nat Cell Biol 2013;15:274-83.
23. Choi N, Zhang B, Zhang L, Ittmann M, Xin L. Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation. Cancer Cell 2012;21: 253-65.
24. Kemp R, Ireland H, Clayton E, Houghton C, Howard L, Winton DJ. Elimination of background recombination: somatic induction of Cre by combined transcriptional regulation and hormone binding affinity. Nucleic Acids Res 2004;32:e92.
25. Heffner CS, Herbert Pratt C, Babiuk RP, Sharma Y, Rockwood SF, Donahue LR, et al. Supporting conditional mouse mutagenesis with a comprehensive cre characterization resource. Nat Commun 2012; 3:1218.
26. Schmidt-Supprian M, Rajewsky K. Vagaries of conditional gene targeting. Nat Immunol 2007;8:665-8.
27. Liu S, Cong Y, Wang D, Sun Y, Deng L, Liu Y, et al. Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts. Stem Cell Reports 2013;2:78-91.
28. Gupta PB, Fillmore CM, Jiang G, Shapira SD, Tao K, Kuperwasser C, et al. Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 2011;146:633-44.
29. Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, Vultur A, et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 2010; 141:583-94.
30. Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Molecular plasticity of human melanoma cells. Oncogene 2003;22:3070-5.